Trial reportFrontiers in immunology2019
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties.
Registry-linked trialOpen access · goldAbstract readClinical TrialMulticenter Study
In one paragraph
Trial report in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06986382 (Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation), which is not on this map. Cited by 45 papers, 5 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 5 pooled it
7.0field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
NCT06986382 phase1 / phase2not yet recruitingnot on this mapstarted 2025, after this paper: background citation
Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset (EO), Medically Refractory (MR) Crohn Disease (CD)
Who cites it
45 citing papers in PubMed, 5 syntheses or guidelines pooled it, 74 citations in OpenAlex.
- Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT practice recommendations.Bone marrow transplantation · 2025Guideline
- Hematopoietic stem cell translation for relapse of psoriasis. Systematic review.Archives of dermatological research · 2025Pooled it
- Efficacy and safety of stem cell transplantation for multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.Scientific reports · 2024Pooled it
- Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.The Cochrane database of systematic reviews · 2022Pooled it
- Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in children and adolescents.The Cochrane database of systematic reviews · 2022Pooled it
- Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation.Frontiers in immunology · 2021Trial
- Hyperacute Graft-Versus-Host Disease.Bone marrow transplantation · 2026Review
- Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Complications Working Party (CWP).Bone marrow transplantation · 2026Article
- Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.Journal of translational internal medicine · 2026Article
- CAR-T cell therapy for juvenile-onset autoimmune diseases: a promising future?Arthritis research & therapy · 2025Review
- Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study.The Lancet. Rheumatology · 2025Article
- Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT.Nature reviews. Neurology · 2025Review
- Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients.Clinical rheumatology · 2024Review
- Review
- Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working Party.Journal of clinical immunology · 2024Article
- Molecular profiling and therapeutic tailoring to address disease heterogeneity in systemic lupus erythematosus.Clinical and experimental medicine · 2024Review
- Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses Group.The journal of allergy and clinical immunology. Global · 2024Article
- Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT.Blood advances · 2024Article
- The EBMT-ADWP and the CIBMTR.Handbook of clinical neurology · 2024Review
- Hematopoietic stem cell transplantation as rescue therapy for refractory autoimmune retinopathy: a case report.Frontiers in immunology · 2024Article
Corrections and comments
- Commented on by
Authors and funding
16 authors at 11 institutions in 7 countries.
Raffaella GrecoUnit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Myriam LabopinEBMT Paris Study Office/CEREST-TC - Department of Haematology, Saint Antoine Hospital - INSERM UMR 938 - Université Pierre et Marie Curie, Paris, France.
Manuela BadoglioEBMT Paris Study Office/CEREST-TC - Department of Haematology, Saint Antoine Hospital - INSERM UMR 938 - Université Pierre et Marie Curie, Paris, France.
Paul VeysDepartment of Bone Marrow Transplantation, Great Ormond Street Hospital, London, United Kingdom.
Juliana M Furtado SilvaDepartment of Bone Marrow Transplantation, Great Ormond Street Hospital, London, United Kingdom.
Mario AbinunGreat North Childrens' Hospital, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Francesca GualandiDivisione Ematologia e Trapianto di Midollo, IRCCS AOU San Martino-IST, Genova, Italy.
Martin BornhauserMedizinische Klinik und Poliklinik I, Carl Gustav Carus University Hospital, Dresden, Germany.
Fabio CiceriUnit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Riccardo SaccardiDepartment of Haematology, Careggi University Hospital, Florence, Italy.
Arjan LankesterIEWP-EBMT Chair: Department of Pediatrics, University Medical Centre, Leiden, Netherlands.
Tobias AlexanderDepartment of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany.
Andrew R GenneryGreat North Childrens' Hospital, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Peter BaderPDWP-EBMT Chair; Division for SCT and Immunology, Department for Children and Adolescents, Frankfurt, Germany.
Dominique FargeUnité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Hôpital St-Louis, AP-HP, Paris, France.
John A SnowdenADWP-EBMT Chair; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
Great North Children's Hospital · GBGreat Ormond Street Hospital · GBInserm · FRVita-Salute San Raffaele University · ITAzienda Ospedaliero-Universitaria Careggi · ITCharité - Universitätsmedizin Berlin · DEDélégation Paris 7 · FREuropean Society for Blood and Marrow Transplantation · NLOspedale Policlinico San Martino · ITSheffield Teaching Hospitals NHS Foundation Trust · GBUniversity Hospital Carl Gustav Carus · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Autoimmune DiseasesGraft vs Host DiseaseHematopoietic Stem Cell TransplantationTransplantation ConditioningAcute DiseaseAdolescentAdultAge FactorsAllograftsChildChild, PreschoolFemaleHumansIncidenceInfantMaleallogeneic hematopoietic stem cell transplantationautoimmune diseaseshematological autoimmune diseaseslong-term outcomenon-hematological autoimmune diseases
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT06986382ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.